For more information about becoming an Investor, please contact:

Craig Richard
President & CEO

(813) 518-2620


Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people’s lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world’s leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

Haresh Patel

Haresh has been with Amgen for 22 years with majority of that time in IT with increasing responsibilities. In December 2020, he was appointed Head of Amgen’s Shared Services Capability Center in Tampa, FL, leading an organization of 1,100 staff across Finance, HR, and IT.

Previously he led teams supporting manufacturing, quality, supply chain, corporate functions with leadership of ERP, analytics, commercial and corporate IT capabilities.

Haresh started his career at a Southern California startup in energy conservation developing process controls systems for seven years and then consulted in pharma for two years.

He holds a BS in Mechanical Engineering from California State Polytechnic University of Pomona and MBA from University of Southern California.

Haresh Patel
Executive Director, Global Business Services